DCAF4L2 and neoplasm: Two main findings in our study: the predictive value of ctDNA combined with conventional serum tumor markers for recurrence and the identification of DCAF4L2 mutation as the crucial gene in ctDNA for poor prognosis of resectable GC require further internal and external validations for their extrapolation in clinical decision‐making.